¿Aún no está registrado?

Información relevante

Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

* = Required fields

Enter your email address

User name *

Clínica e Investigación en Arteriosclerosis (English Edition)

Suscribe to the journal

Clínica e Investigación en Arteriosclerosis (English Edition) Most often read

Clínica e Investigación en Arteriosclerosis (English Edition)

ISSN: 2529-9123

Clínica e Investigación en Arteriosclerosis is the official journal of the Spanish Society of Arteriosclerosis, the Latinoamerican Society of Arteriosclerosis and the Iberolatinoamerican Society of Arteriosclerosis. The journal is the leading Spanish written peer-review journal in the field of arteriosclerosis and its related risk factors. The aim of the journal is primarily the promotion of knowledge and continued medical education, with a special focus in the Spanish-speaking audience, through the publication of relevant research contributions, basic and clinical, in the field and the publication of review and update articles.

See more Open Access Option

Indexed in:

Web of Science, Index Medicus/MEDLINE, Scopus, IBECS, IME, MEDES

See more

Follow us:

Subscribe:

tienda

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more

Impact factor 2024

1.9

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2024

3.7

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2024

0.502

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2024

0.694

View more metrics

Journal Information

Most often read

Vol. 38. Issue. 3

11547

Functional foods and nutraceuticals in the treatment of hypercholesterolemia: Statement of the Spanish Society of Arteriosclerosis 2023

Pablo Pérez-Martínez, Emilio Ros, Juan Pedro-Botet, Fernando Civeira, Vicente Pascual, Carmen Garcés, Rosa Solá, Francisco Pérez-Jiménez, José M. Mostaza

Clin Investig Arterioscler. 2023;35:248-61

11547

Full text access

Open Article

Share

6311

Prevalence rates of chronic kidney disease and its association with cardiometabolic factors and cardiovascular diseases. SIMETAP-CKD study

Antonio Ruiz-Garcia, Ezequiel Arranz-Martínez, Nerea Iturmendi-Martínez, Teresa Fernández-Vicente, Montserrat Rivera-Teijido, Juan Carlos García-Álvarez

Clin Investig Arterioscler. 2023;35:64-74

6311

Full text access

Open Article

Share

5768

Consensus document for lipid profile determination and reporting in Spanish clinical laboratories

Teresa Arrobas Velilla, Carlos Guijarro, Raquel Campuzano Ruiz, Manuel Rodríguez Piñero, José Francisco Valderrama Marcos, Antonio Pérez Pérez, Manuel Antonio Botana López, Ana Morais López, ... en representación del Grupo Multidisciplinar de Trabajo de Lípidos y Riesgo Vascular

Clin Investig Arterioscler. 2023;35:91-100

5768

Full text access

Open Article

Share

5476

Remnant cholesterol, vascular risk, and prevention of atherosclerosis

Xavier Pintó, Marta Fanlo, Virginia Esteve, Jesús Millán

Clin Investig Arterioscler. 2023;35:206-17

5476

Full text access

Open Article

Share

4872

The benefits of measuring the size and number of lipoprotein particles for cardiovascular risk prediction: A systematic review and meta-analysis

Jose A. Quesada, Vicente Bertomeu-González, Domingo Orozco-Beltrán, Alberto Cordero, Vicente F. Gil-Guillén, Adriana López-Pineda, Rauf Nouni-García, Concepción Carratalá-Munuera

Clin Investig Arterioscler. 2023;35:165-77

4872

Full text access

Open Article

Share

4625

Nutritional recommendations in the prevention and treatment of atherogenic dyslipidemia

Vicente Pascual, José Luis Díaz, Jesús Millán Nuñez-Cortés, Pablo Pérez-Martínez

Clin Investig Arterioscler. 2023;35:155-63

4625

Full text access

Open Article

Share

4075

Pemafibrate: PROMINENT failure or an urgent need for therapeutic replacement?

Juan Carlos Laguna Egea, Núria Roglans Ribas, Roger Bentanachs Raset

Clin Investig Arterioscler. 2023;35:202-5

4075

Full text access

Open Article

Share

3847

Update of HDL in atherosclerotic cardiovascular disease

Leonie Schoch, Sebastián Alcover, Teresa Padró, Soumaya Ben-Aicha, Guiomar Mendieta, Lina Badimon, Gemma Vilahur

Clin Investig Arterioscler. 2023;35:297-314

3847

Full text access

Open Article

Share

3770

Clonal hematopoiesis and atherosclerotic cardiovascular disease: A primer

María A. Zuriaga, José J. Fuster

Clin Investig Arterioscler. 2023;35:35-41

3770

Full text access

Open Article

Share

3686

Cardiovascular risk factors and death in South America

Patricio López-Jaramillo, José P. López-López

Clin Investig Arterioscler. 2023;35:195-200

3686

Full text access

Open Article

Share

3494

Doctors’ perception of red wine consumption and cardiovascular health

Javier Espíldora-Hernández, Salvador Martín-Cortés, María José Benítez-Toledo, Inmaculada Coca-Prieto, Miguel Ángel Sánchez-Chaparro, Pedro Valdivielso

Clin Investig Arterioscler. 2023;35:290-3

3494

Full text access

Open Article

Share

3036

Vascular smooth muscle cell aging: Insights from Hutchinson-Gilford progeria syndrome

Magda R. Hamczyk, Rosa M. Nevado

Clin Investig Arterioscler. 2023;35:42-51

3036

Full text access

Open Article

Share

2937

Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study

Agustín Blanco Echevarría, Juan De Dios García Díaz, Assumpta Caixas, Núria Plana Gil, Miguel Ángel Rico Corral, Ian Bridges, Nafeesa Dhalwani, Sònia Gatell Menchen, Kausik K. Ray

Clin Investig Arterioscler. 2023;35:263-71

2937

Full text access

Open Article

Share

2836

Analysis of the evolocumab (Repatha®) patient support program for patients with cardiovascular disease in Colombia

Ángel Alberto García-Peña, Mariana Pineda-Posada, Carol Páez-Canro, César Cruz, Daniel Samacá-Samacá

Clin Investig Arterioscler. 2023;35:280-9

2836

Full text access

Open Article

Share

2834

Dietary modulation of advanced glycation end products metabolism on carotid intima-media thickness in type 2 diabetes patients: From the CORDIOPREV study

Elena M. Yubero-Serrano, Francisco M. Gutiérrez-Mariscal, Purificación Gómez-Luna, Juan F. Alcalá-Diaz, Pablo Pérez-Martinez, José López-Miranda

Clin Investig Arterioscler. 2023;35:105-14

2834

Full text access

Open Article

Share

2719

A case of hypocholesterolemia under research

Ana Camacho, María José Ariza, Nuria Amigó, Patricia Macías Guillén, Miguel Ángel Sánchez Chaparro, Pedro Valdivielso

Clin Investig Arterioscler. 2023;35:244-7

2719

Full text access

Open Article

Share

2520

Hypercholesterolaemia control in Spain: The same situation with different regional realities

Juan Pedro-Botet, Núria Plana, José María Mostaza, Juan José Gómez-Doblas, María Rosa Fernández Olmo, Carlos Escobar Cervantes, José Luis Díaz-Díaz, Raquel Campuzano Ruiz, ... Juan Cosín-Sales

Clin Investig Arterioscler. 2023;35:219-25

2520

Full text access

Open Article

Share

2342

Nutrition, cardiovascular disease risk and climate change

Carlos A. González Svatetz

Clin Investig Arterioscler. 2023;35:101-3

2342

Full text access

Open Article

Share

2202

Association of rs662799 and rs5070 genetic polymorphisms with hypertriglyceridemia and atherogenic dyslipidemia in pediatric patients in Southeast Mexico

Valeria Ovando Gómez, Soraya Amalí Zavaleta Muñiz, Héctor Ochoa-Díaz-López, José Armando Camilo Hernández Contreras, Cesar Antonio Irecta Nájera

Clin Investig Arterioscler. 2023;35:53-63

2202

Full text access

Open Article

Share

2202

Observational study of patients from a Lipid Unit on lipid-modifying therapy for primary and secondary prevention: ULFI Study

Àlex Vila, Estel Pons, Patricia Trinidad García, Daniel Vidal, Sara López, Armand Grau

Clin Investig Arterioscler. 2023;35:272-9

2202

Full text access

Open Article

Share

Ayúdenos a conocerle mejor, indíquenos por favor su especialidad:

Help us get to know you better by telling us your specialty: